Filtros de búsqueda

Lista de obras de Tomasz Byrski

A Lowering of Breast and Ovarian Cancer Risk in Women with a BRCA1 Mutation by Selenium Supplementation of Diet

artículo científico publicado en 2006

A Range of Cancers Is Associated with the rs6983267 Marker on Chromosome 8

A common nonsense mutation of the BLM gene and prostate cancer risk and survival

artículo científico publicado en 2013

A common variant of CDKN2A (p16) predisposes to breast cancer

artículo científico publicado en 2005

A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland

artículo científico publicado en 2006

A high frequency of BRCA2 gene mutations in Polish families with ovarian and stomach cancer

artículo científico publicado en 2003

A high proportion of founder BRCA1 mutations in Polish breast cancer families

artículo científico publicado en 2004

A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer

artículo científico publicado en 2006

A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population

artículo científico publicado en 2010

A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers

artículo científico publicado en 2012

A six-nucleotide deletion in the CASP8 promoter is not associated with a susceptibility to breast and prostate cancers in the Polish population

artículo científico publicado en 2007

A survey of preventive measures among BRCA1 mutation carriers from Poland

scientific article published on 01 February 2007

Abnormalities of chromosome 5q correlate with morphologic features of better prognosis in clear cell renal carcinomas

artículo científico publicado en 1995

Activity of trabectedin in germline BRCA1/2-mutated metastatic breast cancer: results of an international first-in-class phase II study

scientific article published on 01 April 2014

An inherited NBN mutation is associated with poor prognosis prostate cancer

artículo científico publicado en 2012

Are two-centimeter breast cancers large or small?

artículo científico publicado en 2013

Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study

artículo científico publicado en 2012

Association of recurrent mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 with the risk of borderline ovarian tumor

artículo científico publicado en 2022

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

artículo científico publicado en 2015

Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies

artículo científico publicado en 2010

Attitudes toward preventive oophorectomy among BRCA1 mutation carriers in Poland

artículo científico publicado en 2004

BARD1 and breast cancer in Poland

artículo científico publicado en 2007

BRCA1 mutations and colorectal cancer in Poland.

artículo científico publicado en 2010

BRCA1 mutations and prostate cancer in Poland

artículo científico publicado en 2008

BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms

artículo científico publicado en 2009

BRCA1-positive breast cancers in young women from Poland.

artículo científico publicado en 2006

Breast cancer predisposing alleles in Poland

artículo científico publicado en 2005

Breast cancer risk reduction associated with the RAD51 polymorphism among carriers of the BRCA1 5382insC mutation in Poland ⬇️

artículo científico publicado el 1 de mayo de 2003

Breast cancer susceptibility genes

article

CDH1 gene mutations do not contribute in hereditary diffuse gastric cancer in Poland

artículo científico publicado en 2010

CDKN2A common variant and multi-organ cancer risk--a population-based study

artículo científico publicado en 2006

CDKN2A common variants and their association with melanoma risk: a population-based study.

artículo científico publicado en 2005

CDKN2A-positive breast cancers in young women from Poland.

artículo científico publicado en 2006

CHAPTER 22. Selenium and Cancer

artículo científico publicado en 2015

CHEK2 is a multiorgan cancer susceptibility gene

artículo científico publicado en 2004

CHEK2 mutations and HNPCC-related colorectal cancer

artículo científico publicado en 2010

CHEK2 mutations as markers for high risk of breast cancer

artículo científico publicado en 2012

CHEK2-positive breast cancers in young Polish women

scientific article published on 01 August 2006

CYP1B1 and predisposition to breast cancer in Poland

article

Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband

artículo científico publicado en 2009

Characteristics of selected features of hereditary ovarian cancer in carriers of constitutional BRCA1 gene mutation

scientific article published on 01 November 2002

Characterization of a familial RCC-associated t(2;3)(q33;q21) chromosome translocation

artículo científico publicado en 2001

Chemotherapy-induced amenorrhea in patients with breast cancer with a BRCA1 or BRCA2 mutation

scientific article published on 26 August 2013

Cisplatin in breast cancer treatment in BRCA1 carriers

Clinical characteristics of breast cancer in patients with an NBS1 mutation

artículo científico publicado en 2013

Clinical characteristics of hereditary ovarian cancer (HOC) in Poland

scientific article published on 01 September 2002

Clinical features of familial ovarian cancer lacking mutations in BRCA1 or BRCA2

artículo científico publicado en 2004

Clinical genetic services for familial breast cancer in Poland

artículo científico publicado en 1999

Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis

artículo científico publicado en 2015

Combined iPLEX and TaqMan assays to screen for 45 common mutations in Lynch syndrome and FAP patients

artículo científico publicado en 2009

Combined iPLEX and TaqMan assays to screen for 45 common mutations in Lynch syndrome and FAP patients

artículo científico publicado en 2011

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2011

Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers

artículo científico publicado en 2011

Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2012

Common variants of DNA repair genes and malignant melanoma

artículo científico publicado en 2007

Constitutional CHEK2 mutations are associated with a decreased risk of lung and laryngeal cancers

artículo científico publicado en 2008

Copper as diagnostic marker of cancers.

artículo científico publicado en 2015

Corrigendum: Germline RECQL mutations are associated with breast cancer susceptibility

artículo científico publicado en 2016

Coverage of the genetic background of breast cancer in the polish population

artículo científico publicado en 2006

Detection of germline mutations in the BRCA1 gene by RNA-based sequencing

artículo científico publicado en 2001

Direct-to-patient BRCA1 testing: the Twoj Styl experience

artículo científico publicado en 2006

Do founder mutations characteristic of some cancer sites also predispose to pancreatic cancer?

artículo científico publicado en 2016

Early radiation exposures and BRCA1-associated breast cancer in young women from Poland

artículo científico publicado en 2008

Effect of CHEK2 missense variant I157T on the risk of breast cancer in carriers of other CHEK2 or BRCA1 mutations

artículo científico publicado en 2008

Epistatic relationship between the cancer susceptibility genes CHEK2 and p27

scientific article published on 01 March 2007

Erratum: Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations?

artículo científico publicado en 2007

Estrogen receptor status in CHEK2-positive breast cancers: implications for chemoprevention

artículo científico publicado en 2008

Folic acid and cancer risk in BRCA1 carriers.

artículo científico publicado en 2012

Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer

artículo científico publicado en 2000

Founder mutations in the BRCA1 gene in west Belarusian breast-ovarian cancer families

artículo científico publicado en 2001

Genetic contribution to all cancers: the first demonstration using the model of breast cancers from Poland stratified by age at diagnosis and tumour pathology

article

Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2010

Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations?

artículo científico publicado en 2006

Germline MSH2 and MLH1 mutational spectrum in HNPCC families from Poland and the Baltic States

artículo científico publicado en 2002

Germline MSH2 and MLH1 mutational spectrum including large rearrangements in HNPCC families from Poland (update study)

artículo científico publicado en 2005

Germline RECQL mutations are associated with breast cancer susceptibility

artículo científico publicado en 2015

Hereditary breast and ovarian cancer

artículo científico publicado en 2008

Hereditary ovarian cancer in Poland.

artículo científico publicado en 2003

Higher antitumor activity of trabectedin in germline BRCA2 carriers with advanced breast cancer as compared to BRCA1 carriers: A subset analysis of a dedicated phase II trial

artículo científico publicado en 2017

Impact of BRCA1 mutation on survival after early onset breast cancer.

artículo científico publicado en 2012

Influence of selected lifestyle factors on breast and ovarian cancer risk in BRCA1 mutation carriers from Poland

artículo científico publicado en 2006

Integrin beta3 Leu33Pro polymorphism increases BRCA1-associated ovarian cancer risk

artículo científico publicado en 2007

Iron as diagnostic marker of cancer.

artículo científico publicado en 2015

Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium

artículo científico publicado en 2011

Low prevalence of CDKN2A/ARF mutations among early-onset cancers of breast, pancreas and malignant melanoma in Poland

artículo científico publicado en 2008

Low-risk Genes and Multi-organ Cancer Risk in the Polish Population

artículo científico publicado en 2006

Lynch syndrome mutations shared by the Baltic States and Poland.

artículo científico publicado en 2013

MC1R common variants, CDKN2A and their association with melanoma and breast cancer risk

artículo científico publicado en 2006

Magnesium as a diagnostic marker of cancer.

artículo científico publicado en 2015

Male to female ratio among offspring of BRCA1 mutation carriers

artículo científico publicado en 2005

Management of ovarian and endometrial cancers in women belonging to HNPCC carrier families: review of the literature and results of cancer risk assessment in Polish HNPCC families

artículo científico publicado en 2015

Meeting abstracts from the Annual Conference on Hereditary Cancers 2015: Szczecin, Poland. 24-25 September, 2015.

artículo científico publicado en 2017

Meeting abstracts from the Annual Conference on Hereditary Cancers 2016: Szczecin, Poland. 14-15 September 2016.

artículo científico publicado en 2017

Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks

scientific article published on 25 October 2006

Molecular Analyses in Diagnosis of High Genetic Predispositions to Malignancies

artículo científico publicado en 2000

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

artículo científico publicado en 2013

Mutations predisposing to breast cancer in 12 candidate genes in breast cancer patients from Poland.

artículo científico publicado en 2014

Mutations spectrum in hereditary disorders predisposing to occurrence of intestine polyposis in Poland.

artículo científico publicado en 2012

NOD2 variants and the risk of malignant melanoma

artículo científico publicado en 2005

Neoadjuvant chemotherapy with Cisplatin in BRCA1 mutation carriers – results of treatment

artículo científico publicado en 2012

Neoadjuvant chemotherapy with dose dense MVAC is associated with improved survival after radical cystectomy compared to other cytotoxic regimens: A tertiary center experience

artículo científico publicado en 2021

Neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients

New EPCAM founder deletion in Polish population

artículo científico publicado en 2017

Non-random transmission of mutant alleles to female offspring of BRCA1 carriers in Poland

artículo científico publicado en 2003

Novel germline mutations in the adenomatous polyposis coli gene in Polish families with familial adenomatous polyposis

artículo científico publicado en 2004

Ovarian cancer risk in Polish BRCA1 mutation carriers is not associated with the prohibitin 3' untranslated region polymorphism

artículo científico publicado en 2008

Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers

artículo científico publicado en 2012

Ovarian cystadenoma as a characteristic feature of families with hereditary ovarian cancers unassociated with BRCA1 and BRCA2 mutations.

artículo científico publicado en 2004

Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy

artículo científico publicado en 2009

Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients

artículo científico publicado en 2014

Pathological complete response after cisplatin neoadjuvant therapy is associated with the downregulation of DNA repair genes in BRCA1-associated triple-negative breast cancers

artículo científico publicado en 2016

Pathological complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients.

artículo científico publicado en 2015

Pathology of breast cancer in women with constitutional CHEK2 mutations

artículo científico publicado en 2005

Plasma micronutrients, trace elements, and breast cancer in BRCA1 mutation carriers: an exploratory study

scientific article published on 11 May 2012

Pleomorphic adenoma of salivary glands does not appear to be a BRCA-1-dependent tumour in a Polish cohort.

artículo científico publicado en 2008

Population Screening of CHEK2 Mutations in Poland

artículo científico publicado en 2006

Population screening for cancer family syndromes in the west pomeranian region of poland

artículo científico publicado en 2006

Predictors of survival for breast cancer patients with a BRCA1 mutation

artículo científico publicado en 2017

Prevalence of the NOD2 3020insC mutation in aggregations of breast and lung cancer

artículo científico publicado en 2005

Prognostic factors in Polish patients with BRCA1-dependent ovarian cancer

artículo científico publicado en 2016

RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies

artículo científico publicado en 2007

Recurrent Mutations in BRCA1, BRCA2, RAD51C, PALB2 and CHEK2 in Polish Patients with Ovarian Cancer

artículo científico publicado en 2021

Recurrent mutations of BRCA1 and BRCA2 in Poland: an update

artículo científico publicado en 2014

Recurrent mutations of BRCA1, BRCA2 and PALB2 in the population of breast and ovarian cancer patients in Southern Poland

artículo científico publicado en 2016

Response to neo-adjuvant chemotherapy in women with BRCA1-positive breast cancers

artículo científico publicado en 2007

Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients

artículo científico publicado en 2008

Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer

artículo científico publicado en 2012

Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer

artículo científico publicado en 2011

Selenium (Se) and breast cancer risk

Selenium (Se) and the risk of breast, ovarian and prostate cancers

artículo científico publicado en 2012

Selenium and genotypes as marker of risk in BRCA1 mutation carriers

artículo científico publicado en 2012

Selenium and the risk of cancer in BRCA1 carriers

artículo científico publicado en 2011

Selenium as a marker of cancer risk and of selection for control examinations in surveillance

artículo científico publicado en 2015

Selenium as diagnostic marker of cancers.

artículo científico publicado en 2015

Selenium as marker for cancer risk and prevention

artículo científico publicado en 2012

Should all BRCA1 mutation carriers with stage I breast cancer receive chemotherapy?

artículo científico publicado en 2013

Survival from breast cancer in patients with CHEK2 mutations.

artículo científico publicado en 2014

Synergistic interaction of variants in CHEK2 and BRCA2 on breast cancer risk

artículo científico publicado en 2008

Systemic treatment for hereditary cancers: a 2012 update

artículo científico publicado en 2013

Ten-year survival in patients with BRCA1-negative and BRCA1-positive breast cancer

artículo científico publicado en 2013

The 3' untranslated region C > T polymorphism of prohibitin is a breast cancer risk modifier in Polish women carrying a BRCA1 mutation

artículo científico publicado en 2006

The 3020insC Allele of NOD2 Predisposes to Cancers of Multiple Organs

artículo científico publicado en 2005

The 3020insC allele of NOD2 predisposes to early-onset breast cancer

artículo científico publicado en 2005

The Conductivity and pH Values of Dispersions of Nanospheres for Targeted Drug Delivery in the Course of Forced Equilibrium Dialysis

artículo científico publicado en 2015

The DIRC1 gene at chromosome 2q33 spans a familial RCC-associated t(2;3)(q33;q21) chromosome translocation

artículo científico publicado en 2001

The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland

artículo científico publicado en 2013

The RAD51 135 G>C polymorphism modifies breast cancer and ovarian cancer risk in Polish BRCA1 mutation carriers

artículo científico publicado en 2007

The VEGF_936_C>T 3'UTR polymorphism reduces BRCA1-associated breast cancer risk in Polish women

artículo científico publicado en 2008

The diameter of metastasis in positive sentinel lymph node biopsy affects axillary tumor load in early breast cancer

scientific article published on 13 February 2019

The impact of oophorectomy on survival after breast cancer in BRCA1-positive breast cancer patients

artículo científico publicado en 2016

The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutation

artículo científico publicado en 2013

The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study

artículo científico publicado en 2016

The presence of prostate cancer at biopsy is predicted by a number of genetic variants

artículo científico publicado en 2013

The risk of breast cancer in women with a BRCA1 mutation from North America and Poland

artículo científico publicado en 2011

The risk of breast cancer in women with a CHEK2 mutation

artículo científico publicado en 2012

The variant allele of the rs188140481 polymorphism confers a moderate increase in the risk of prostate cancer in Polish men

artículo científico publicado en 2015

Transmission of mutant alleles to female offspring of BRCA1 carriers in Poland

artículo científico publicado en 2005

Usefulness of polymorphic markers in exclusion of BRCA1/BRCA2 mutations in families with aggregation of breast/ovarian cancers.

artículo científico publicado en 2003

Variant alleles of the CYP1B1 gene are associated with colorectal cancer susceptibility

artículo científico publicado en 2010

Vitamin D receptor variants and breast cancer risk in the Polish population

artículo científico publicado en 2008

Vitamin D receptor variants and the malignant melanoma risk: a population-based study

artículo científico publicado en 2009

Why choose the treatment with cisplatin for BRCA1 breast cancers patients?

artículo científico publicado en 2012

XPD common variants and their association with melanoma and breast cancer risk

artículo científico publicado en 2006

Zinc and breast cancer risk

artículo científico publicado en 2012

Zinc as diagnostic marker of cancers.

artículo científico publicado en 2015

[Germline mutation of BRCA1 gene in Polish families with strong aggregation of breast and/or ovarian cancer based on coding sequence analysis using the SSCP method]

artículo científico publicado en 2003

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda